Corcept Therapeutics | CORT - Operating Profit

Stock Price
39.68
Daily Change
-1.02 -2.51%
Monthly
13.53%
Yearly
-42.03%
Q1 Forecast
38.64

Corcept Therapeutics reported $10.22M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Acadia Pharmaceuticals USD 35.76M 3.38M Sep/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
ANI Pharmaceuticals USD 22.83M 7.66M Sep/2025
Ardelyx USD 4.67M 19.07M Sep/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Corcept Therapeutics USD 10.22M 16.46M Sep/2025
Eli Lilly USD 8.39B 1.37B Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Merck USD 6.24B 318M Dec/2025
Novartis USD 4.5B 363M Sep/2025
Novartis USD 4.58B 879M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Supernus Pharmaceuticals USD -60.18M 72.32M Sep/2025
TG Therapeutics USD 29.36M 5.48M Sep/2025